Tuesday, November 17, 2026 4,523 lists 78,992 records on file
List your app or device

  1. Home
  2. AI Drug Discovery Software
  3. CONVERGE

CONVERGE

San Francisco, California

On the record

Commercial access
Verge describes engagement models ranging from full target-discovery campaigns to focused human-relevance assessments.vergelabs.com · read 14 Nov 2026
Company
Verge Labs says it started as Verge Genomics in 2015 and became Verge Labs in 2026.vergelabs.com · read 14 Nov 2026
Data collection
VergeDB is built from brain tissue partnerships and includes transcriptomic, genetic, clinical, and multi-omics data.vergelabs.com · read 14 Nov 2026
Model
Its model infers an individual patient's brain molecular state from a routine blood draw and predicts drug response.vergelabs.com · read 14 Nov 2026
Product
CONVERGE is an AI operating system for neuroscience drug development combining foundation models and systems-biology workflows.vergelabs.com · read 14 Nov 2026
Program enablement
CONVERGE helps teams evaluate target pathways, patient subgroups, preclinical models, and indication opportunities.vergelabs.com · read 14 Nov 2026
Scale
The company's platform data page reports 12,000 brain transcriptomes, 6,000+ neurological patients and controls, and 15M single-cell profiles.vergelabs.com · read 14 Nov 2026
Security and integrations
The opened official product pages do not state security certifications or third-party integrations.vergelabs.com · read 14 Nov 2026
Support
Verge says it aims to reply to platform and partnership inquiries within two business days.vergelabs.com · read 14 Nov 2026
Target discovery
The platform identifies disease signatures and targets using multimodal patient data and human tissue and genetics.vergelabs.com · read 14 Nov 2026
Training data
The foundation model is trained on proprietary multimodal CNS patient data and can be tuned with program- and trial-specific data.vergelabs.com · read 14 Nov 2026
Trial optimization
It stratifies trial populations by molecular endotype and identifies likely-benefit subgroups and pharmacodynamic biomarkers.vergelabs.com · read 14 Nov 2026
Users
The product is presented for drug developers working on neuroscience and CNS programs.vergelabs.com · read 14 Nov 2026

Alternatives to CONVERGE

Every alternative, ranked